Dr. Swords on Anti-Tumor Effects of IMG-98 in AML
January 6th 2016Ronan T. Swords, MD, discusses preclinical findings demonstrating that the small-molecule inhibitor IMG-98 effectively augments pro-differentiation effects of all-trans-retinoic acid–based therapies in acute myeloid leukemia.
Read More